EDUCATION AND TRAINING

M.D., University of California School of Medicine, Davis, 1989

Internship and Residency in Internal Medicine, University of Washington, 1989-1992

Chief Resident, VA Medical Center, Seattle, Washington, 1992-1993

Endocrinology Fellow, University of Washington Affiliated Hospitals, 1993-1995

OFFICE ADDRESS

University of Washington Medical Center
Department of Medicine
1959 NE Pacific St.
Campus Box 356420 (AA512)
Seattle, WA 98195

Email: banawalt@medicine.washington.edu
Phone: (206) 897-1409
Fax: (206) 616-4663


HONORS

Undergraduate:

• Honors Program
• Cum Laude
• Dean's List
• Sigma Xi, a national scientific research society
• Krassowski Award for exemplary anthropological thesis

• Alpha Omega Alpha 1988
• Merck Award for outstanding scholarship, 1989

• 1997 Endocrine Society Travel Award
• 1999 Endocrine Society Travel Award
• 1999 University of Washington Paul Beeson Award (for excellence in teaching)
• 2005 America's Best Doctors
• 2005 The Endocrine Society and Pfizer, Inc. International Award for Excellence in Published Clinical Research in The Journal of Clinical Endocrinology & Metabolism in 2004
• 2004, 2005, 2007 Outstanding Federal Employee honoree
• 2007 University of Washington Endocrinology Fellows’ Teaching Award
• 2008 America's Best Doctors
• 2008 Washington State’s Best Doctors (Washington State Magazine)

• American Board of Internal Medicine 1992, 2002
• American Board of Endocrinology 1995, 2005

• Fellow, American College of Physicians (member since 1993)
• Endocrine Society 1997-present
• Special Programs Committee member 2004-2007
• Annual Program Steering Committee member 2007-2010
• Annual Program Clinical Chair 2010-11

• Male contraception
• Male hypogonadism
• Male reproductive physiology

1. Anawalt BD, Amory JK, Herbst KL, Bremner WJ, Matsumoto AM. Low-dosage levonorgestrel plus testosterone effectively suppresses spermatogenesis. J Androl. 2005;26(3):405-13.
2. Darby E and Anawalt BD. Male hypogonadism: an update on diagnosis and treatment. Treat Endocrinol. 2005;4(5):1-18.
3. Cornia PB and Anawalt BD. Male hormonal contraceptives: a potentially patentable and profitable product. Expert Opinion on Therapeutic Patents. 2005, 15:1727-1737.
4. Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist, J Clin Endocrinol Metab. 2006;91:4374-80.
5. BD Anawalt. Update on the development of male hormonal contraceptives. Curr Op Invest Drugs, 2007;8:318-323.
6. Amory JK, Coviello AD, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ. Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin. Fertil Steril. 2008;89:380-6.
7. Amory JK,Wang C, Swerdoloff RS, Anawalt BD, Matsumoto AM, Page ST, Bremner W, Walker SE, Haberer LJ, Clark RV. The effect of 5α-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, PSA and sexual function. J Urol, 2008;179:2333-8.
8. Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ, Elliesen J, Gu YQ, Kersemaekers WM, McLachlan RI, Meriggiola MC, Nieschlag E, Sitruk-Ware R, Vogelsong K, Wang XH, Wu FC, Zitzmann M, Wang C. Determinants of the Rate and Extent of Spermatogenic Suppression during Hormonal Male Contraception: An Integrated Analysis. J Clin Endocrinol Metab. 2008;93;1774-83.
9. Roth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST. Serum LH Correlates Highly with Intratesticular Steroid Levels in Normal Men. J Androl. 2010;31:138-45.
10. Anawalt BD. Guidelines for testosterone therapy for men: How to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab, in press.